Back
Bio-Techne 10K Form
Sell
39
TECH
Bio-Techne
Last Price:
$46.76
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-06 | 10Q | TECH/Bio-Techne Quarterly |
2024-02-07 | 10Q | TECH/Bio-Techne Quarterly |
2023-11-07 | 10Q | TECH/Bio-Techne Quarterly |
2023-05-08 | 10Q | TECH/Bio-Techne Quarterly |
2023-02-07 | 10Q | TECH/Bio-Techne Quarterly |
2022-11-07 | 10Q | TECH/Bio-Techne Quarterly |
Receive TECH News And Ratings
See the #1 stock for the next 7 days that we like better than TECH
TECH Financial Statistics
Sales & Book Value
Annual Sales: | $1.2B |
---|---|
Cash Flow: | $31M |
Price / Cash Flow: | 34.37 |
Annual Sales: | $12.87 |
Price / Book: | 3.68 |
Profitability
EPS (TTM): | 0.82000 |
---|---|
Net Income (TTM): | $131.7M |
Gross Margin: | $769.7M |
Return on Equity: | 6.38% |
Return on Assets: | 4.89% |
Bio-Techne Earnings Forecast
Key Bio-Techne Financial Ratios
-
The Gross Profit Margin over the past 36 years for TECH is 66.41%.
-
The Selling, General & Administrative Expenses for TECH have been equal to 34.24% of Gross Profit Margin.
-
The Research & Development expenses have been 8.34% of Revenue.
-
The Interest Expense is 9.36% of Operating Income.
-
The Net Earning history of TECH is 14.50% of Total Revenues.
-
Per Share Earnings over the last 36 years have been positive in 27 years.
Bio-Techne Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Life Sciences Tools & Services |
Sector: | Health Care |
Current Symbol: | TECH |
CUSIP: | 09073M |
Website: | bio-techne.com |
Debt
Debt-to-Equity Ratio: | 0.16 |
---|---|
Current Ratio: | 3.71 |
Quick Ratio: | 2.23 |
Price-to-Earnings
Trailing P/E Ratio: | 45.07 |
---|---|
Forward P/E Ratio: | 22.51 |
TECH Technical Analysis vs Fundamental Analysis
Sell
39
Bio-Techne (TECH)
is a Sell
Is Bio-Techne a Buy or a Sell?
-
Bio-Techne stock is rated a SellThe current Bio-Techne [TECH] share price is $46.78. The Score for TECH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.